(Q59187306)

https://dunedinstudy.otago.ac.nz/publications

0 references

1 reference

Joseph M Boden

4

0 references

David M. Fergusson

object named as

David M Fergusson

series ordinal

1

0 references

Richie Poulton

series ordinal

2

object named as

Richie Poulton

0 references

author name string

Paul F Smith

series ordinal

3

0 references

language of work or name

English

0 references

publication date

21 January 2006

0 references

published in

The BMJ

0 references

volume

332

0 references

issue

7534

0 references

page(s)

172-5

0 references

cites work

Cannabinoid physiology and pharmacology: 30 years of progress.

1 reference

12 December 2020

Cannabis as a risk factor for psychosis: systematic review

1 reference

12 December 2020

Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia

1 reference

12 December 2020

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

12 December 2020

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

12 December 2020

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

12 December 2020

Role of endogenous cannabinoids in synaptic signaling

1 reference

12 December 2020

Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex

1 reference

12 December 2020

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

1 reference

12 December 2020

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

1 reference

12 December 2020

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

12 December 2020

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

1 reference

12 December 2020

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

1 reference

12 December 2020

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

1 reference

12 December 2020

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

12 December 2020

Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain

1 reference

12 December 2020

Phenotype of schizophrenia: a review and formulation

1 reference

12 December 2020

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

12 December 2020

Tests of causal linkages between cannabis use and psychotic symptoms

1 reference

12 December 2020

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

12 December 2020

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

12 December 2020